Charles Osborne
Finanzdirektor/CFO bei POLAREAN IMAGING PLC
Aktive Positionen von Charles Osborne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POLAREAN IMAGING PLC | Direktor/Vorstandsmitglied | 22.02.2021 | - |
Finanzdirektor/CFO | 29.04.2019 | - |
Karriereverlauf von Charles Osborne
Ehemalige bekannte Positionen von Charles Osborne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Finanzdirektor/CFO | 05.07.2015 | 01.04.2019 |
Unternehmenssekretär | 01.07.2015 | 01.04.2019 | |
SCYNEXIS, INC. | Finanzdirektor/CFO | 01.11.2003 | 30.06.2015 |
International Murex Technologies Corp.
International Murex Technologies Corp. Medical SpecialtiesHealth Technology International Murex Technologies Corp. develops medical diagnostic products. It provides infectious disease screening services. The company is headquartered in Norcross, GA. | Finanzdirektor/CFO | - | - |
Nobex Corp.
Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Finanzdirektor/CFO | - | - |
Ausbildung von Charles Osborne
The University of North Carolina at Charlotte | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 5 |
Undergraduate Degree | 1 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SCYNEXIS, INC. | Health Technology |
POLAREAN IMAGING PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
International Murex Technologies Corp.
International Murex Technologies Corp. Medical SpecialtiesHealth Technology International Murex Technologies Corp. develops medical diagnostic products. It provides infectious disease screening services. The company is headquartered in Norcross, GA. | Health Technology |
Nobex Corp.
Nobex Corp. Pharmaceuticals: MajorHealth Technology Protein Delivery Inc. is drug delivery company. It specializes in proprietary polymer-based technology for the stabilization and oral delivery of proteins and peptides as well as the delivery of small molecules across the blood-brain barrier. The company's technology also enables the delivery of drugs into the brain to treat diseases of the central nervous system. Protein Delivery is located in Durham, NC | Health Technology |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Charles Osborne
- Erfahrung